MAFLD

Clinical trials for MAFLD explained in plain language.

Never miss a new study

Get alerted when new MAFLD trials appear

Sign up with your email to follow new studies for MAFLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 4 Not yet finished but already full! 1 Completed 2

No approved drugs for fatty liver: could this diabetes medication be the answer?

Disease control Ongoing

This study is testing if a medication called semaglutide, given as a weekly injection for three years, can improve liver health in people with fatty liver disease linked to obesity and diabetes. It will involve 70 adults and closely monitor their liver condition, weight, and hear…

Matched conditions: MAFLD

Sponsor: Center of target therapy • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

MAFLD

Get alerted when new MAFLD trials appear

No approved drugs for fatty liver: could this diabetes medication be the answer?